
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ELV market cap is 99.18B. The company's latest EPS is USD 26.3028 and P/E is 18.35.
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 42.65B | 42.58B | 43.89B | 45.11B | 45.44B |
Operating Income | 1.26B | 3.2B | 3.27B | 1.67B | 946M |
Net Income | 856M | 2.25B | 2.3B | 1.02B | 418M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 121.87B | 138.64B | 156.6B | 171.34B | 177.01B |
Operating Income | 7.06B | 8.74B | 8.62B | 8.75B | 9.09B |
Net Income | 4.57B | 6.1B | 6.03B | 5.99B | 5.98B |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 108.93B | 111.89B | 112.99B | 116.53B | 116.89B |
Total Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Equity | 0 | 0 | 0 | 0 | 0 |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 86.62B | 97.46B | 102.77B | 108.93B | 116.89B |
Total Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Equity | 0 | 0 | 0 | 0 | 0 |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | N/A | N/A | N/A | N/A | N/A |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | N/A | N/A | N/A | N/A | N/A |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | N/A | N/A | N/A | N/A | N/A |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | N/A | N/A | N/A | N/A | N/A |
Market Cap | 99.18B |
Price to Earnings Ratio | 18.35 |
Price to Sales Ratio | 0.62 |
Price to Cash Ratio | 13.24 |
Price to Book Ratio | 0.94 |
Dividend Yield | 1.57% |
Shares Outstanding | 227.35M |
Average Volume (1 week) | 2.01M |
Average Volume (1 Month) | 1.68M |
52 Week Change | -14.79% |
52 Week High | 567.26 |
52 Week Low | 362.21 |
Spread (Intraday) | 27.35 (6.17%) |
Company Name | Elevance Health Inc |
Address |
220 virginia avenue indianapolis, indiana 46204 |
Website | https://ww.elevancehealth.com |
Industry | hospital & medical svc plans (6324) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions